Young Investigator Campaign
We’re raising $75,000 to continue to invest in more Young Investigators.
Help us launch their bold ideas in the pursuit to find a cure for cancer.
The Cancer Research Foundation’s mission is to raise funds to fund early-career cancer scientists with the goal of contributing to transformational events in the prevention, treatment and cure for cancer.
We are “cancer research venture philantropists,” making early investments in the ideas and minds of innovative and entrepreneurial cancer researchers.
Young Investigator Awards
The Young Investigator Awards was created to enable promising young investigators to initiate successful scientic careers.
These awards provide the seed capital to nurture young scientists in the pursuit of independent hypotheses, to develop the preliminary data to compete for major grants, and to inspire scientific innovation in the war against cancer.
Why Cancer Research?
In 2016, 1.6 million people were diagnosed with cancer according to the *National Cancer Institute
About 595,690 Americans are expected to die of cancer each year in the United States*
Worldwide cancer cases are expected to rise 50% from 14 million to 21 million by 2030*
Your Donation Hard at Work
Funding Bold Ideas
The Young Investigator Award has funded ideas from all types of cancers from breast, prostate, lung cancer, leukemia and treatments such as immunotherapy.
Supporting Innovative Minds
Over the past 60 years, the CRF invested in over 170 Young Investigators. Many have gone on to make significant discoveries in cancer science.
Rising Stars with Bold New Ideas
Milan Chheda, MD, Assistant Professor of Medicine at Washington University St. Louis received a 2016 Young Investigator Award for his work to fight Glioblastoma, one of the most deadly forms of brain cancer.
In a recent publication, Dr. Chheda, along with a team of researchers discovered a potential way to use the zika virus to treat Glioblastoma. Your generous support has enabled the Cancer Research Foundation to invest in Dr. Chheda, and his continuing work in the fight against cancer.
Pioneers who Paved the Way
As early as the mid-1970’s, the CRF was funding early career cancer scientists such as Janet Rowley, MD. Using new techniques of chromosome identification, she was among the first to prove that some cancers were cause by genetic mutations. This research, carried out at the University of Chicago and supported by the CRF, led the way to proving linkages between genetics and cancer, a theory rejected by the scientific community until that time.
Rowley stated, “The most difficult time in the career of a beginning young scientist is the first few years. One has no ‘track record’ just when the need for money to hire a technician to help with experiments, to buy supplies and equipment, is the greatest.”